Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence

  1. Nicola Alessio
  2. Tiziana Squillaro
  3. Giovanni Di Bernardo
  4. Giovanni Galano
  5. Roberto De Rosa
  6. Mariarosa AB Melone
  7. Gianfranco Peluso
  8. Umberto Galderisi  Is a corresponding author
  1. Luigi Vanvitelli Campania University, Italy
  2. ASL Napoli 1, Italy
  3. National Research Council (CNR), Italy

Abstract

Senescent cells secrete several molecules, collectively named senescence-associated secretory phenotype (SASP). In the SASP of cells that became senescent following several in vitro chemical and physical stress, we identified the IGFBP-4 protein that can be considered a general stress mediator. This factor appeared to play a key role in senescence-paracrine signaling. We provided evidences showing that genotoxic injury, such as low dose irradiation, may promote an IGFBP-4 release in bloodstream both in mice irradiated with 100 mGy X-ray and in human subjects that received Computer Tomography. Increased level of circulating IGFBP-4 may be responsible of pro-aging effect. We found a significant increase of senescent cells in the lungs, heart, and kidneys of mice that were intraperitoneally injected with IGFBP-4 twice a week for two months. We then analyzed how genotoxic stressors may promote the release of IGFBP-4 and the molecular pathways associated with the induction of senescence by this protein.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nicola Alessio

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  2. Tiziana Squillaro

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Giovanni Di Bernardo

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Giovanni Galano

    Centro P.S.I. Napoli Est - Barra, Naples, Italy, ASL Napoli 1, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Roberto De Rosa

    Centro P.S.I. Napoli Est - Barra, Naples, Italy, ASL Napoli 1, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Mariarosa AB Melone

    Medical, Surgical, Neurological, Metabolic Sciences, and Aging, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Gianfranco Peluso

    Institute of Agri-Environmental Biology and Forestry (IBAF), National Research Council (CNR), Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  8. Umberto Galderisi

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    For correspondence
    umberto.galderisi@unicampania.it
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0909-7403

Funding

Regione Campania (CUP B23D18000250007)

  • Umberto Galderisi

Regione Campania (CUP B23D18000250007)

  • Gianfranco Peluso

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The animals were handled in compliance with the protocols that were approved by the Animal Care and Use Committee of Luigi Vanvitelli Campania University. Italian Ministry of Health ethical approval n. 67/2012 A

Human subjects: Bone marrow aspirate samples were obtained from healthy donors (age 10-18 years) after informed consent. Campania Region Ethical Committee approval n. 317/2016 PR

Copyright

© 2020, Alessio et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,463
    views
  • 183
    downloads
  • 30
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicola Alessio
  2. Tiziana Squillaro
  3. Giovanni Di Bernardo
  4. Giovanni Galano
  5. Roberto De Rosa
  6. Mariarosa AB Melone
  7. Gianfranco Peluso
  8. Umberto Galderisi
(2020)
Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence
eLife 9:e54523.
https://doi.org/10.7554/eLife.54523

Share this article

https://doi.org/10.7554/eLife.54523

Further reading

    1. Cancer Biology
    2. Stem Cells and Regenerative Medicine
    Alison G Barber, Cynthia M Quintero ... Tannishtha Reya
    Research Article

    Despite advances in therapeutic approaches, lung cancer remains the leading cause of cancer-related deaths. To understand the molecular programs underlying lung cancer initiation and maintenance, we focused on stem cell programs that are normally extinguished with differentiation but can be reactivated during oncogenesis. Here, we have used extensive genetic modeling and patient-derived xenografts (PDXs) to identify a dual role for Msi2: as a signal that acts initially to sensitize cells to transformation, and subsequently to drive tumor propagation. Using Msi reporter mice, we found that Msi2-expressing cells were marked by a pro-oncogenic landscape and a preferential ability to respond to Ras and p53 mutations. Consistent with this, genetic deletion of Msi2 in an autochthonous Ras/p53-driven lung cancer model resulted in a marked reduction of tumor burden, delayed progression, and a doubling of median survival. Additionally, this dependency was conserved in human disease as inhibition of Msi2 impaired tumor growth in PDXs. Mechanistically, Msi2 triggered a broad range of pathways critical for tumor growth, including several novel effectors of lung adenocarcinoma. Collectively, these findings reveal a critical role for Msi2 in aggressive lung adenocarcinoma, lend new insight into the biology of this disease, and identify potential new therapeutic targets.